Application 202586
- Type
- ANDA
- Sponsor
- BWXT ITG
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | INDIUM IN 111 OXYQUINOLINE | INDIUM IN-111 OXYQUINOLINE | INJECTABLE;INJECTION | 1mCi/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72536-0920 | Indium In 111 Oxyquinoline | Indium In-111 Oxyquinoline | BWXT ITG Canada, Inc. | ANDA | Current |
| 72536-0920 | Indium In 111 Oxyquinoline | Indium In-111 Oxyquinoline | BWXT Medical Ltd. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 55229 | ORIG | 2018-08-20 |